Innate immunity is the first line of defense in the body's immune system, providing rapid and nonspecific protection against a wide range of pathogens. It is an evolutionarily ancient form of immunity that acts immediately upon encountering foreign invaders. Key components of innate immunity include physical barriers like the skin and mucous membranes, as well as cellular components such as phagocytes (like neutrophils and macrophages) and natural killer (NK) cells. These cells are equipped to recognize and eliminate pathogens without the need for prior exposure. Innate immunity also involves the activation of the complement system, a group of proteins that enhance the immune response by promoting inflammation, phagocytosis, and the destruction of pathogens. While innate immunity provides rapid protection, it lacks the specificity and memory characteristic of adaptive immunity. Innate and adaptive immunity work collaboratively, with innate responses initiating the defense against pathogens, and adaptive responses developing over time for more precise and targeted protection. Dysregulation of innate immunity can lead to various diseases, including inflammatory conditions and autoimmune disorders. Understanding the complexities of innate immunity is crucial for developing strategies to modulate the immune system and combat infections and diseases effectively.
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan